Related Experiment Video

Updated: Aug 16, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Pathophysiology of cardiovascular disease and renal failure

Ralf Dikow1, Martin Zeier, Eberhard Ritz

  • 1Department of Nephrology, University Hospital of Heidelberg, Bergheimer Strasse 56a 691115, Heidelberg, Germany.

Cardiology Clinics
|August 9, 2005
PubMed

Insights

Cardiovascular events are common in kidney disease patients. This review covers cardiovascular risk factors, accelerated atherosclerosis, and target organ damage in renal disease.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in patients with renal disease.
  • Renal disease is associated with a unique and complex CVD risk factor profile.
  • Understanding these risks is crucial for patient management.

Purpose of the Study:

  • To review the epidemiology of cardiovascular (CV) events in early and end-stage renal disease.
  • To summarize classic and nonclassic CV risk factors in renal patients.
  • To highlight evidence on accelerated atherogenesis and target organ damage in renal disease.

Main Methods:

  • Literature review of epidemiological studies.
  • Synthesis of data on CV risk factors in renal populations.
  • Analysis of evidence on atherogenesis and target organ effects.

Main Results:

  • Cardiovascular event rates are significantly elevated across all stages of renal disease.
  • Both traditional (e.g., hypertension, diabetes) and non-traditional (e.g., inflammation, mineral metabolism disorders) risk factors contribute to CV risk.
  • Renal disease accelerates the process of atherosclerosis, particularly affecting central arteries and the heart.

Conclusions:

  • Cardiovascular complications represent a major challenge in the management of renal disease.
  • A comprehensive approach addressing both classic and nonclassic risk factors is essential.
  • Further research is needed to develop effective preventive and therapeutic strategies for cardiovascular disease in renal patients.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...